Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.61 |
| ▸ | RAB9A | P51151 | 5/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | CNR2 | P34972 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.47 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.44 |
| ▸ | SMYD3 | Q9H7B4 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29655774 | 0.95 | NPC1 (0.56) | NPC1RAB9ATP53HPGDNFKB1 | |
| SCHEMBL31743230 | 0.91 | NPC1 (0.53) | NPC1RAB9ATP53HPGDNFKB1 | |
| SCHEMBL29655732 | 0.90 | NPC1 (0.62) | NPC1RAB9ATP53HPGDNFKB1 | |
| SCHEMBL29696137 | 0.80 | CYP26A1 (0.47) | NPC1RAB9AHPGDNFKB1NFKB2 | |
| SCHEMBL30353220 | 0.80 | RARA (0.54) | NPC1RAB9ATSHR | |
| SCHEMBL28347731 | 0.80 | RARA (0.54) | NPC1RAB9ATSHR | |
| SCHEMBL29655815 | 0.80 | SMN1; SMN2 (0.47) | NPC1RAB9ASMN1; SMN2GAAPTGER4 | |
| SCHEMBL29655794 | 0.79 | MAPK14 (0.45) | RAB9AHPGDMAPK11MAPK14KMT2A | |
| SCHEMBL30353262 | 0.76 | KDM4E (0.54) | NPC1RAB9AHPGDTSHR | |
| SCHEMBL29655785 | 0.73 | CYP26A1 (0.46) | NPC1RAB9AHPGDNFKB1NFKB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022138793-A1 | COMBINATION BETWEEN EP2 RECEPTOR ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR AND/OR EP4 RECEPTOR ANTAGONIST | 小野薬品工業株式会社 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022102731-A1 | CANCER TREATMENT BY COMBINED USE OF EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR | 小野薬品工業株式会社 | 2022-05-19 | — | — | WO | disclosed |